Examining Autistic Traits in Children with ADHD: Does the Autism Spectrum Extend to ADHD?

Phyllis Green and Randolph Cōwen Institute for Pediatric Neuroscience, Child Study Center of the NYU Langone Medical Center, 215 Lexington Avenue, New York, NY 10016, USA.
Journal of Autism and Developmental Disorders (Impact Factor: 3.06). 11/2010; 41(9):1178-91. DOI: 10.1007/s10803-010-1135-3
Source: PubMed

ABSTRACT We examined to what extent increased parent reports of autistic traits in some children with Attention Deficit Hyperactivity Disorder (ADHD) are the result of ADHD-related symptoms or qualitatively similar to the core characteristics of autism spectrum disorders (ASD). Results confirm the presence of a subgroup of children with ADHD and elevated ratings of core ASD traits (ADHD(+)) not accounted for by ADHD or behavioral symptoms. Further, analyses revealed greater oppositional behaviors, but not greater ADHD severity or anxiety, in the ADHD(+) subgroup compared to those with ADHD only. These results highlight the importance of specifically examining autistic traits in children with ADHD for better characterization in studies of the underlying physiopathology and treatment.

  • European Neuropsychopharmacology 10/2012; 22:S422. DOI:10.1016/S0924-977X(12)70662-4 · 5.40 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Emerging research suggests that physical activity may be an effective non-pharmaceutical intervention approach for childhood developmental disorders. Findings indicate that both single bouts of activity and chronic physical activity associate with improved mental health and classroom performance in children with attention-deficit/hyperactivity disorder and children with autism spectrum disorders. This review describes the research in this area and identifies limitations and challenges to the translation of these findings to promote physical activity in clinical practice and educational policy. © 2014 The Society for Research in Child Development, Inc.
    Monographs of the Society for Research in Child Development 12/2014; 79(4):93-118. DOI:10.1111/mono.12132 · 5.50 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective: Our aim was to investigate the factors associated with a clinical decision to use risperidone in children and adolescents with a primary diagnosis of Attention Deficit Hyperactivity Disorder (ADHD) and to investigate autistic traits (ATs) and their influence on treatment decisions in this population Methods: We retrospectively compared four treatment groups of children with a primary diagnosis of ADHD [no psychotropics group, NPG (n=73, mean age (in years) = 9.22±2.94); stimulant-only, S (n=184, mean age (in years) = 10.52±2.98); risperidone-only, R (n=51, mean age (in years) = 10.18±3.52); and stimulant plus risperidone, SR (n=30, mean age (in years) = 9.37±2.71] from a private child and adolescent psychiatry clinic. Baseline assessments, in addition to a semistructured interview, included a sociodemographic information form, the parent-rated Child Behavior Checklist for ages 6 to 18 (CBCL-6-18) and the parent and teacher-rated SNAP-IV scale (Swanson, Nolan and Pelham). Results: There were significant between-group differences on CBCL T scores for total problems, externalizing problems, social problems, thought problems, attention problems, and aggression (all p<0.05) and on the parent SNAP inattention and combined scores (one-way ANOVA). The SR group had significantly higher scores (i) on the mentioned subscales of the CBCL when compared with the NPG and S groups, (ii) on the CBCL social problems subscale when compared with the R group, (iii) on the parent SNAP inattention scale when compared with the NPG and R groups and (iv) on the parent-rated SNAP total score when compared with the other 3 groups (Tukey post hoc test). Sixty-four children above the CBCL-AT cutoff had higher scores than those of children below the cutoff on parent and teacher-rated individual ADHD symptoms. In the logistic regression analysis, the clinician’s decision to use risperidone (either alone or in combination with stimulants) was significantly related to higher scores on the CBCL social problems (p=0.025) and thought problems (p=0.039) subscales. The presence of AT as a category, however, did not predict treatment assignment. Conclusion: In this clinical sample, parent-rated social problems and thought problems were associated with the clinician’s decision to use risperidone in the treatment of ADHD cases (alone or in combination with stimulants). ADHD children with AT had more severe symptoms of ADHD and displayed more learning disability. However, AT profile as a category was not significantly associated with the use of risperidone. The better characterization of non-ADHD symptoms of ADHD children (social and emotional symptoms) may help to develop more individualized clinical interventions, such as nonpharmacological interventions for social development, which may result in a reduction in the use of medications targeting these symptoms in this group of children. Keywords: Attention deficit hyperactivity disorder; risperidone; autistic traits; children
    Bulletin of Clinical Psychopharmacology 12/2014; 24(4):333-41. DOI:10.5455/bcp.20140616123454 · 0.37 Impact Factor

Full-text (3 Sources)

Available from
Jun 6, 2014